In any case, in a pancreatic ductal adenocarcinoma model, loss of TIGAR did not improve survival, and even amplified metastatic spread [41], and in colorectal cancer patients, a higher TIGAR plasma level was associated with lower risk of metastasis [42]. Here, TIGAR is linked to pancreatic ductal adenocarcinoma.